C-Reactive protein in dilated cardiomyopathy

Cardiology

Volumn 91, Issue 4, 1999, Pages 215-219

  Kaneko, Katsumi ^a   Kanda, Tsugiyasu ^b   Yamauchi, Yasuhiko ^a   Hasegawa, Akira ^a   Iwasaki, Tsutomu ^a   Arai, Masashi ^a   Suzuki, Tadashi ^c   Kobayashi, Isao ^b   Nagai, Ryozo ^a  

^a Nagasaki University   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

C reactive protein; Dilated cardiomyopathy; Inflammation; Prognosis, cardiomyopathy

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATIGUE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEART VENTRICULOGRAPHY; HIGH RISK PATIENT; HUMAN; IMMUNITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDITIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE VENTRICULOGRAPHY; SURVIVAL;

ADULT; AGED; C-REACTIVE PROTEIN; CARDIOMYOPATHY, DILATED; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FATIGUE; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; PROGNOSIS; RADIONUCLIDE VENTRICULOGRAPHY; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032737142     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006913     Document Type: Article

References (27)

1. Katz AM: Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 1990;322:100-110.
2. Lee WH, Packer M: Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe heart failure. Circulation 1986;73:257-267.
3. Cohn JN, Levine TB, Olivani MT, Ganberg V, Lura D, Francis GS, Simon AB, Rector T: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-825.
4. Clerand JG, Dargie HJ, Ford I: Mortality in heart failure. Clinical variables of prognostic value. Br Heart J 1987;58:572-582.
5. Pepys MB: The actue phase response and C-reactive protein; in Weatherall DJ, Leingham JGG, Warrell DA (eds): Oxford Textbook of Medicine, ed 3. Oxford, Oxford University Press, 1995, pp 1527-1533.
6. Shine B, de Beer FC, Pepys MB: Solid phase radioimmunoassays for C-reactive protein. Clin Chim Acta 1981;117:13-23.
7. Miyatake K, Okamoto M, Kinoshita N, Izumi S, Owa M, Takao S, Sakakibara H, Nimura Y: Clinical applications of a new type of real-time two-dimensional Doppler flow imaging system. Am J Cardiol 1984;54:857-868.
8. Sahn OJ, DcMaria AN, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurement. Circulation 1978;58:1072-1083.
9. Pietila K, Harmonien A, Teppo AM: Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator. Ann Med 1991;23:529-535.
10. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, Ogawa S: C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997;96:778-784.
11. Kaneko K, Kanda T, Nakazato Y, Kobayashi I, Nagai R: Expression of interleukin-6 in myocardium and coronary arteries in patients with myocardial infarction. Res Commun Mol Pathol Pharmacol 1997;97:3-12.
12. Limas CJ, Goldenberg IF, Limas C: Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy; Correlation with disease severity and cardiac antibodies. Circulation 1995;91:631-634.
13. Matsumori A, Yamada T: Suzuki H, Matoba Y, Sasayama S: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72:561-566.
14. O'Connell JB: The role of myocarditis in end-stage dilated cardiomyopathy. Texas Heart Inst J 1987;14:268-275.
15. Kanda T, Araki M, Nakano M, Imai S, Suzuki T, Kobayashi I: Chronic effect of losartan in a murine model of dilated cardiomyopathy: Comparison with captopril. J Pharmacol Exp Ther 1995;273:955-958.
16. Ikram H, Williamson HG, Won M, Crozier IG, Wells EJ: The course of idiopathic dilated cardiomyopathy in New Zealand. Br Heart J 1987;57:521-527.
17. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B: Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1989;14:564-570.
18. Packer M, Leier CV: Survival in congestive heart failure during treatment with drugs with positive inotropic actions. Circulation 1987; 75:IV56-IV63.
19. Wilson JR: Use of antiarrhythmic drugs in patients with heart fialure: Clinical efficacy, hemodynamic results, and relation to survival. Circulation 1987;75:IV64-IV63.
20. Newmank TJ, Maskin CS, Dennick LG, Meyer JH, Hallows BG, Copper WH: Effects of captopril on survival in patients with heart failure. Am J Med 1988;84:140-144.
21. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL: The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47:525-531.
22. Unverferth DV, Magorien RD, Moeschberger ML, Backer PB, Fetters JK, Leier CV: Factors influencing the one-year mortality of cardiomyopathy. Am J Cardiol 1984;54:147-152.
23. Diaz RA, Obasohan A, Oakley CM: Prediction of outcome in dilated cardiomyopathy. Br Heart J 1987;58:393-399.
24. Romeo F, Pelliccia F, Cianfrocca C, Gallo P, Barilla F, Cristofani R: Determinants of end-stage idiopathic dilated cardiomyopathy: A multivariate analysis of 104 patients. Clin Cardiol 1989;12:387-392.
25. Abramson SV, Burke JF, Kelly JJ, Kitchen JG, Dougherty MJ, Yih DF, McGreehin FC, Shuck JW, Phiambolis TP: Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Am Intern Med 1992;116:888-895.
26. Miric M, Miskovic A, Brkic S, Vasiljevic J, Keserovic N, Pesic M: Long-term follow-up of patients with myocarditis and idiopathic dilated cardiomyopathy after immunomodulatory therapy. FEMS Immunol Med Microbiol 1994;10:65-74.
27. McNamara DM, Rosenblum WD, Janosko KM, Trost MK, Villaneuva FS, Demetris AJ, Murali S, Feldman AM: Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997;95: 2476-2478.